Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance

International Journal of Cancer. Journal International Du Cancer
Dieter FuchsFaranak Azarbayjani

Abstract

High-risk neuroblastoma is a rapidly growing tumor with a survival rate below 50%. A new treatment strategy is to administer chemotherapeutic drugs metronomically, i.e., at lower doses and frequent intervals. The aim of the study was to investigate the effects of GMX1777, a chemotherapeutic drug affecting cellular energy metabolism, in a mouse model for high-risk neuroblastoma. Female SCID mice were injected s.c. with MYCN-amplified human neuroblastoma cells and randomized to either treatment with GMX1777 or vehicle. In some animals, treatment was discontinued allowing tumor relapse. Treatment response was evaluated using the pediatric preclinical testing program (PPTP). Immunohistochemistry and qRT-PCR was performed on tumor cryosections to investigate the microscopic and molecular changes in tumors in response to GMX1777. Despite an increase in vessel density, tumor regression and a high group response score according to PPTP criteria was induced by GMX1777 without inducing drug resistance. Treatment resulted in inhibition of tumor cell proliferation, vessel maturation, reduced hypoxia, increased infiltration of MHC class II negative macrophages and expansion of the nonvascular stromal compartment. Decreased stromal VEGF-A an...Continue Reading

References

Dec 1, 1979·The American Journal of Surgical Pathology·T A SeemayerG Tremblay
Aug 1, 1970·Experimental and Molecular Pathology·D J CrockerJ C Geer
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A LivingstoneT E Wheldon
Dec 15, 1996·Experimental Cell Research·M IvarssonB Gerdin
Feb 23, 1999·The American Journal of Pathology·E WassbergR Christofferson
Feb 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·A IanaroG Cirino
Feb 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·A PetterssonH F Dvorak
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S J CotterillJ Imeson
Jun 30, 2000·Microvascular Research·P Dore-DuffyJ A Rafols
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Apr 30, 2002·Pediatric Research·Asa SvenssonRolf Christofferson
Dec 21, 2002·Differentiation; Research in Biological Diversity·Margareta M Mueller, Norbert E Fusenig
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Jan 30, 2003·Trends in Cardiovascular Medicine·David G Jackson
Apr 16, 2003·Annals of Internal Medicine·Daniel J Brat, Timothy B Mapstone
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruno De BernardiUNKNOWN Italian Co-Operative Group for Neuroblastoma
Jun 5, 2003·Nature Medicine·Rakesh K Jain
Sep 8, 2004·Experimental Cell Research·Victor L J L ThijssenArjan W Griffioen
Sep 25, 2004·Journal of Cellular Physiology·Maria L MachedaJames D Best
Feb 16, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Alexei V SalnikovKristofer Rubin
Mar 4, 2005·The American Journal of Pathology·Shuqing LiuSusan L Cohn
May 3, 2005·Bioorganic & Medicinal Chemistry Letters·Ernst BinderupLise Binderup
Jun 14, 2005·Cancer Cell·Johanna A Joyce
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Oct 27, 2006·Pediatric Blood & Cancer·Peter J HoughtonMalcolm A Smith
Dec 14, 2006·Advances in Experimental Medicine and Biology·Linda HolmquistSven Påhlman
Apr 4, 2007·Journal of Bioenergetics and Biomembranes·Peter L Pedersen
Jun 26, 2007·Lancet·John M MarisSusan L Cohn
Oct 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-ShawNihal Ahmad
Nov 3, 2007·Surgical Oncology·Titilope A Ishola, Dai H Chung
Jan 19, 2008·Biochemical and Biophysical Research Communications·Uffe Høgh OlesenSøren Jensby Nielsen
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Trevor LucasSeyedhossein Aharinejad

❮ Previous
Next ❯

Citations

Jul 28, 2012·Dental Clinics of North America·Sahng G KimJeremy J Mao
Jul 29, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michail KastelloriziosDiane J Burgess
Jun 4, 2013·Blood Cells, Molecules & Diseases·Xue Yan CuiLing Sun
Nov 7, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Barry E KennedyShashi A Gujar
Jul 25, 2013·The Journal of Biological Chemistry·Alessia GrozioSantina Bruzzone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.